Certain 4-phenoxy(or phenylthio)-3-n-acylated-sulfonamido-pyridi

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2602948F, 2602948G, C07D21371, A61K 3144

Patent

active

040556506

ABSTRACT:
This invention relates to new derivatives of pyridine having hypo-uricemic or hypolipemic properties.
The new derivatives of pyridine may be represented by the following general formula: ##STR1## in which X represents an oxy or thio group, R.sub.1 represents hydrogen, a group of the formula R.sub.3 NHCO (II), wherein R.sub.3 represents a C.sub.1 -C.sub.4 -alkyl, cycloalkyl or possibly substituted phenyl group, or a group of the formula R.sub.4 --CO (III) in which R.sub.4 represents a C.sub.1- C.sub.4 -alkyl group or a possibly substituted phenyl group, and R', R" and R'" represent each a possible substituent selected from the group comprising the halogens, the trifluoromethyl and the C.sub.1- C.sub.4 alkyl groups.

REFERENCES:
patent: 3674794 (1972-07-01), Mizzoni et al.
patent: 3819639 (1974-06-01), DeLarge et al.
patent: 3904636 (1975-09-01), DeLarge et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Certain 4-phenoxy(or phenylthio)-3-n-acylated-sulfonamido-pyridi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Certain 4-phenoxy(or phenylthio)-3-n-acylated-sulfonamido-pyridi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain 4-phenoxy(or phenylthio)-3-n-acylated-sulfonamido-pyridi will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-123366

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.